UNION therapeutics Research Services ApS: Financial statements 2022
CVR: 40807098
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
UNION therapeutics Research Services ApS (CVR 40807098) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 492,372 and a net result of DKK 268,506 compared with DKK 220,214 the year before. That is a decrease of 17.6% compared with the year before. The profit margin was 54.5%. Equity in the 2022 report amounted to DKK 528,720. The solvency ratio was 70.7%.
- Revenue
- DKK 492,372
- Gross Profit
- DKK 492,372
- Profit/Loss
- DKK 268,506
- Equity
- DKK 528,720
- Total Assets
- DKK 747,680
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 492K | 492K | 269K | 529K | - |
| 2021 | 597K | 597K | 220K | 260K | - |
Official annual report
Keep an eye on UNION therapeutics Research Services ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
UNION therapeutics Research Services ApS has published its annual report for 2021. Revenue came to DKK 597,372, and the net result was DKK 220,214.
About UNION therapeutics Research Services ApS
UNION therapeutics Research Services ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2019. The company has been dissolved on 2 December 2024. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee (2024). In 2023, the company reported revenue of DKK 258,145 and a net result of DKK 18,416 compared with DKK 268,506 the year before. Equity in the 2023 report amounted to DKK 547,136.
